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A hybrid volumetric dose veriﬁcation method for
single‐isocenter multiple‐target cranial SRS
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Abstract
A commercial semi‐empirical volumetric dose veriﬁcation system (PerFraction [PF],
Sun Nuclear Corp.) extracts multi‐leaf collimator positions from the electronic portal
imaging device movies collected during a pre‐treatment run, while the rest of the
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delivered control point information is harvested from the accelerator log ﬁles. This
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cylindrical phantom. The targets ranged in size from 0.8 to 3.6 cm and in number

combination is used to reconstruct dose on a patient CT dataset with a fast superposition/convolution algorithm. The method was validated for single‐isocenter multi‐
target SRS VMAT treatments against absolute radiochromic ﬁlm measurements in a
from 3 to 10 per plan. A total of 17 ﬁlms rotated at different angles around the
cylinder axis were analyzed. Each of 27 total targets was intercepted by at least one
ﬁlm, and 2–4 different ﬁlms were analyzed per plan. Film dose was always scaled to
the ion chamber measurement in a high‐dose, low‐gradient area deliberately created
at the isocenter. The planar dose agreement between PF and ﬁlm using 3%(Global
dose‐difference normalization)/1 mm gamma analysis was on average 99.2 ± 1.1%.
The point dose difference in the low‐gradient area in the middle of every target was
below 3%, while PF‐reconstructed and ﬁlm dose centroids for individual targets
showed submillimeter agreement when measured on a well aligned accelerator. Volumetrically, all voxels in all plans agreed between PF and the primary treatment
planning system at the 3%/1 mm level. With proper understanding of its advantages
and shortcomings, the tool can be applied to patient‐speciﬁc QA in routine radiosurgical clinical practice.
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1 | INTRODUCTION

ET AL.

and delivery log ﬁles is supplied as input to the independent dose
calculation algorithm that reconstructs the expected deliverable dose

Brain metastases are a common oncological diagnosis1 and intracra-

distribution on the patient CT dataset.20

nial stereotactic radiosurgery (SRS) has evolved as an important
modality of treatment/palliation for that disease.2,3 It was demonstrated that even with multiple metastases the SRS treatment could
provide reasonable local control,4,5 and a multi‐institutional observational study suggested that clinical outcomes for patients with 5–10

2 | METHODS
2.A | System description

individual metastases treated by SRS alone may be non‐inferior to

The method evaluated in this paper is a part of PerFRACTION (PF)

those with 2–4 targets.6,7 While conceptually straightforward in prin-

software suite (Sun Nuclear Corp, Melbourne, FL) that provides a

ciple, multi‐target SRS poses logistical challenges. As the number of

number of options for pre‐ and on‐treatment patient‐speciﬁc dosi-

treated metastases increases, the traditional SRS paradigm of one

metric analysis. We focused on the pre‐treatment patient‐speciﬁc

isocenter per lesion leads to prohibitively long treatment times and

QA (called Fraction 0) and chose the input conﬁguration that, in our

had to be revisited with the goal of simultaneously treating multiple

opinion, provided the most advantageous balance between the

targets. Interestingly, while dynamic conformal arcs were the main-

empirical and calculation portions of the analysis. The software runs

stay of linac‐based radiosurgery for years, the feasibility of single‐iso-

on a central dedicated Windows server and all routine user interac-

center multiple‐target (SIMT) approach was ﬁrst demonstrated with

tions occur through a web browser‐based interface. At the heart of

a relatively new volumetric modulated arc therapy (VMAT) tech-

the method is the graphics processing unit‐accelerated superposi-

nique.8,9 The most recent commercial implementation (HyperArc,

tion/convolution dose calculation algorithm described and validated

Varian Medical Systems) offers reﬁnements in terms of planning

previously.21,22 The beam model can be customized by the vendor

10

automation and collision prevention.

11

Alternatively, Huang et al.

proposed a concept of single isocenter dynamic conformal arcs

to ﬁt the user's data, although a generic model for the accelerator
class conﬁguration proved sufﬁcient in this work.

(SIDCA), whereby each lesion is treated by a dedicated group of

The system is compatible with contemporary Varian and Elekta

dynamic conformal arcs but all groups share the same isocenter posi-

linacs. The veriﬁcation process starts with transferring the patient

tioned between all targets. This allows for more efﬁcient dynamic

CT and ﬁnalized Plan, Structure, and Dose DICOM RT objects from

arc treatment, as only one isocenter setup is necessary, and the

the treatment planning system to PF. This establishes a new patient/

couch angles and arc directions can be optimized for fastest delivery.

plan in the system. The same plan is transferred to the record‐and‐

A version of SIDCA is commercially implemented in Automatic Brain

verify (R&V) system and is then delivered to the EPID operating in a

Metastases Planning Element software by BrainLab.12,13 It creates a

cine mode. The compressed (MPEG) EPID movies, one per beam, are

series of dynamic arcs and each lesion can be covered by all or some

stored after the delivery in a speciﬁed network directory that is

of them, depending on the relative position, to minimize normal tis-

monitored by PF, automatically transferred to the PF server, and

sue irradiation. Both techniques by necessity produce treatment

associated with the individual beam(s) found in the RT Plan object.

plans containing complex MLC apertures, and it is prudent to per-

The accelerator log ﬁles are processed in the exact same fashion.

form patient‐speciﬁc end‐to‐end test prior to commencing the treat-

The EPID image frames are then synchronized to the log ﬁles to

ment.14 The number of small, off‐center targets poses a unique

determine the exact duration of time when each EPID frame was

challenge to dosimetry devices commonly used for such tests. The

acquired. This is achieved by ﬁrst creating a series of predicted

approach should possess high spatial resolution as the lesions could

images based on the projection of the RT Plan ﬂuence to the plane

be of the order of 1 cm or less in size. At the same time, the targets

of the EPID. The predicted images of every segment (or multitude of

could be fairly wide spread, which negates the advantages of dedi-

segments) are then compared to the measured frames to ﬁnd the

cated “stereotactic” detector arrays with small detector pitch, that

maximum similarity. The measured frame with maximum similarity is

typically have a relatively small active area under the assumption

considered to be acquired during the same segments as the best

15

that the lesion would be located at isocenter.

Moreover, the tar-

matching predicted image.

gets randomly placed in three dimensions naturally call for a 3D veri-

With the synchronization process completed, the frames are then

ﬁcation approach. The only true 3D dosimeters with high spatial

analyzed to determine the location of each MLC during that time

resolution are radiochromic gels/polymers,16,17 one of which was

period. An edge detection algorithm is used to ﬁnd the MLC edges

18

successfully used for VMAT‐based SIMT validation.

However, volu-

on EPID frames. From this information, an internal RT Plan is

metric radiochromic dosimetry is sufﬁciently cumbersome at this

devised, with the control points (CP) created by amalgamation of the

point to prevent its use for routine patient‐speciﬁc quality assur-

EPID movies and log ﬁles. Speciﬁcally, the time‐resolved multi‐leaf

ance.19 Therefore, a more practical method is needed that combines

collimator (MLC) apertures are derived from the EPID ﬁles, indepen-

some high spatial resolution measurements with 3D dose recon-

dent of the accelerator logs. The positions of the rest of the acceler-

struction over a volume of an adult head. One such approach, which

ator axes per CP (fractional monitor units (MU), gantry angle, etc.)

we validate in this paper, is a hybrid technique whereby information

are determined from the delivery log ﬁles. In addition to MLC posi-

collected from the accelerator electronic portal imaging device (EPID)

tions, if radiation is detected on regions of the EPID which were
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supposed to be covered by the jaws, corrected jaw positions are

scans served as the baseline datasets for CBCT alignment of the

incorporated into the internal RT Plan so that such unexpected radi-

phantom with the ﬁlm holder in different orientations.

ation is properly accounted for in the ﬁnal dose calculation. With CP
point information thus complete, the dose calculation is triggered.
The PF calculation voxel size is the larger of the TPS or the mini-

2.B.2 | Treatment planning

mum set in PF, which was 2.5 mm in this work. This voxel size was

The datasets were transferred to the TPS (Pinnacle v. 14.0, Philips

set to obtain a reasonable compromise between the calculation

Radiation Oncology Systems, Fitchburg, WI) and the isocenter was

speed and accuracy and the dose distribution is not distinguishable

placed based on the known locations of the ﬁlm ﬁducials visible on

from the one calculated with a 2 mm voxel14 at the 1% dose‐differ-

CT scans. The next step was devising regions of interest (ROI) for

ence/1 mm distance to agreement level. The resulting semi‐empirical

planning. Six plans of two types were created. The ﬁrst three plans

dose distribution can be compared to the planned one by standard

in Table 1 contain only three spherical target ROIs each, with the

23

gamma analysis

and dose‐volume histogram evaluation.

goal of creating conformal plans without additional constraints. Each
target is intersected in the middle by at least one ﬁlm plane. Plans

2.B | Planning and delivery
2.B.1 | The phantom
A MultiPlug (Sun Nuclear) phantom is a 15.1 cm diameter Poly

4–6 are rooted in real patient datasets. The patient RT Structure
DICOM objects were processed to make transfer to the phantom
CT possible. The organs‐at‐risk (OAR) had to be moved some to
ensure that they were positioned within the cylinder. The targets

(methyl methacrylate) (PMMA) cylinder, further encased in a PMMA

were also nudged to intersect with at least one ﬁlm plane each. An

shell with 26.6 cm outer diameter (Fig. 1). The phantom has inter-

example arrangement can be seen in Fig. 1A, which shows the tar-

changeable inserts to accommodate either an ion chamber (in this

gets (red) above, below, and intersecting the coronal plane. Two to

A1SL, Standard Imaging, Middleton, WI) or a

four planes were measured per plan. Overall, 17 ﬁlms intersecting

13.2 × 16.5 cm2 piece of radiochromic ﬁlm. The ﬁlm insert has small

27 targets were analyzed. In addition to those, each plan contained

sharp points at ﬁve locations to imprint ﬁducial marks on the ﬁlm.

a 2 cm diameter spherical structure (green in Fig. 1A) drawn at the

Those were augmented by small amounts of Barium paste to provide

isocenter and planned to achieve uniform 18 Gy dose for normaliza-

high‐contrast but low‐artifact ﬁducials for eventual cone‐beam CT

tion purposes.

case, 0.06 cm

3

(CBCT) alignment on a linear accelerator. The plug with the ﬁlm

VMAT optimization employed two full coplanar and two partial

insert can be freely rotated in the shell around the cylinder axis. The

(164° rotation) non‐coplanar (±25° table rotation) arcs. The ﬂat

phantom was scanned on a 16‐slice Big Bore scanner (Philips Medi-

caudal edge of the phantom precluded the use of vertex beams

cal, Cleveland, OH) according to our standard SRS protocol (sequen-

common in SRS, which however should not affect the generality of

tial scans with 1.25 mm slice thickness), with four different ﬁlm

the tests. All plans used A 6 MV ﬂattening ﬁlter free beam with

plane orientations: coronal, sagittal, and ±45° obliques. The plane

the maximum repetition rate of 1400 MU/min and were calculated

angular positions were established directly with a digital level. These

with 2° CP increment and a 2 mm isotropic dose grid resolution.

(a)

(b)

F I G . 1 . (a) A CT‐based coronal plane cut through the center of the assembled phantom. The inner cylinder, the outer shell and the ﬁlm
rectangle in the middle (coronal orientation) can all be appreciated. An example of ROI arrangement is presented, with multiple targets (red),
normal structures (blue) and a central 2 cm target sphere (green) for ion chamber normalization, the latter common to all plans. (b) A
photograph of the MultiPlug with the partially inserted ﬁlm holder and ion chamber. Note that for the actual measurements the ion chamber
insert replaced ﬁlm at the isocenter.
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T A B L E 1 The plans, target sizes and positions, and ﬁlm plane orientations. The maximum ﬁled sizes (jaws) for each plan are also presented.
Plan

No. of
Targets

Targets max dimensions, cm

Target center distance from isocenter, cm

Max. ﬁeld size
(X × Y), cm2

Measurement
planes orientation

1

3

1.3, 1.2, 2.1

3.6, 5.0, 5.5

10.1 × 12.0

Cor.,Obl.45°,Obl.135°

2

3

1.1, 1.2, 2.4

5.8, 5.9, 6.2

12.7 × 15.0

Cor.,Sag.,Obl.135°

3

3

1.3, 1.2, 2.9

5.5, 4.5, 4.7

11.1 × 13.0

Obl.45°,Obl.135°

4

3

2.2, 1.1, 0.8

4.3, 3.6, 5.4

11.3 × 10.5

Obl.45°,Obl.135°

5

5

2.2, 1.1, 0.8, 3.6, 2.3

4.3, 3.6, 5.4, 4.7, 4.0

10.9 × 12.5

Cor.,Obl.45°,Ob1.135°

6

10

2.2, 1.1, 0.8, 3.6, 2.3, 1.4, 1.4, 0.9, 1.2, 1.1

4.3, 3.6, 5.4, 4.7, 4.0, 4.0, 5.1, 6.3, 3.4, 6.3

12.2 × 12.5

Cor.,Sag.,Obl.45°, Obl.135°

The prescriptions followed RTOG 0320 protocol,24 depending on
the target size: 24 Gy to the planning target volume (PTV) <2 cm,

2.C.1 | Film measurements

18 Gy to the PTV between 2.1–3 cm, and 15 Gy to the 3.1–4 cm

Extended range Gafchromic ﬁlm (EBT‐XD, Ashland Inc., Bridgewater,

PTV. Plans 4‐6 also employed common OAR objectives from the

NJ) was chosen because of the wide dynamic range,26,27 well‐suited
for SRS veriﬁcation. An additional beneﬁt is greatly reduced scanner

same protocol.

lateral response artifact.26 Both calibration and measurement ﬁlm

2.B.3 | Beam delivery

pieces were scanned in the same orientation with respect to the
original sheet they came from. Templates sized to ﬁt the calibration

All experiments were performed on a TrueBeam v.2.5 linear accel-

(smaller) and measurement ﬁlms were made out of black paper to

erator (Varian Medical Systems, Palo Alto, CA) equipped with a

reproducibly position the ﬁlms in the center of the ﬂatbed document

standard 120‐leaf Millennium MLC, a 6 degree of freedom (6DOF)

scanner (Expression 11000XL, Epson Seiko Corporation, Nagano,

couch, and an aS1000 EPID. The EPID pixel size is 0.39 mm,

Japan). Exposed ﬁlms were scanned 24 h after irradiation, in trans-

which translates into 0.26 mm effective size at isocenter when

mission mode and without any corrections. Resolution was set at 72

the EPID is positioned 150 cm from the source. Prior to measure-

dpi (0.35 mm/pixel). Every ﬁlm was scanned in the same position and

ments the alignment of mechanical, MV, and kV isocenters of the

orientation before the exposure to account for any background non‐

accelerator were veriﬁed by two methods. First, the built‐in IsoCal

uniformity. Film calibration was performed with a 6MV beam in a

veriﬁcation routine

25

was employed. It demonstrated the maximum

water‐equivalent solid phantom in the dose range from 2 to30 Gy.

MV isocenter deviation of 0.42 mm (with no couch rotation) and

The ﬁlms were analyzed with RIT v.6.6 software (Radiologic

negligible translational and angular misalignment of the kV and

Imaging Technology, Inc., Colorado Springs, CO). The ﬁlm scans were

MV imagers. Second, an independent MLC‐based Winston‐Lutz

transferred to RIT as 48 bit color image ﬁles. The background cor-

test with 12 angular combinations covering the full range of accel-

rection was applied using the built‐in routine. The ﬁlm ﬁducials

erator motions conﬁrmed the maximum treatment isocenter devia-

marks were aligned to the pre‐deﬁned geometric template, and the

tion of 0.41 mm.

dose after application of the calibration curve was further scaled to

The plan information was transferred to the accelerator through

match the ion chamber dose at the isocenter. The ﬁlm dose was

Mosaiq v. 2.4 (Elekta Impac, Sunnyvale, CA) R&V system. Before

averaged for scaling over 13 central pixels in the craniocaudal direc-

delivery, the phantom was ﬁrst leveled and then aligned in 3D by

tion, corresponding approximately to the chamber active volume

CBCT to the ﬁlm ﬁducials in the desired plane orientation with the

length. There is no direct interface for importing dose in arbitrary

help of the 6DOF couch.

plane from PF to RIT. Instead, volumetric dose was exported from
PF as a DICOM RT Dose ﬁle and then imported to Pinnacle using a

2.C | Dose comparison

custom script. After that, planar doses in required orientations could
be extracted from Pinnacle on a 1 mm grid using the built‐in IMRT

The core of this work is dosimetric comparisons between PF

QA tool and imported into RIT. Three types of tests were performed

reconstructed dose and ﬁlm measurements. The strategy was to

using RIT. First, an overall dose comparison was done using gamma

convert the relative dose measured by calibrated ﬁlm to absolute

analysis with 3% (global dose‐difference normalization), 1 mm dis-

by normalization to the ion chamber dose at isocenter. To that

tance to agreement, and 10% low‐dose cutoff threshold criteria. The

end, the ion chamber reading in the MultiPlug phantom was col-

RIT digital gamma analysis routine modeled after Depuydt et al28

lected under the standard conditions (parallel‐opposed horizontal

was used. For completeness, the same analysis was performed for

ﬁelds) and converted to dose by comparison with

Pinnacle. Second, the point doses in the low‐gradient region near

10 × 10 cm

2

Pinnacle point dose in the same geometry. Subsequently, an ion

the center of each target were extracted from the ﬁlm dose proﬁles

chamber measurement was performed for each plan and the

(averaged over 3 pixels, or about 1 mm) and compared to PF. The

resulting dose at isocenter was used to scale dose for the ﬁlms

distribution of dose‐differences was tested for normality by D'Agos-

belonging to that plan.

tino & Pearson test implemented in GraphPad Prism statistical
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to radiosurgical applications, the alignment of measured and recon-

T A B L E 2 Planar gamma analysis passing rates (3%G/1 mm) for PF
and Pinnacle vs. ﬁlm.

structed proﬁles at the 50% level (dose centroid) was evaluated.

Gamma passing rate (%)

package (v. 7.0, GraphPad Software, La Jolla, CA). Finally, paramount

Horizontal and vertical proﬁles were drawn in RIT through the cen-

Plan

No. of Targets

Planes

ter of each target on every ﬁlm image. The vertical proﬁle always

100

corresponded to the craniocaudal direction. The horizontal proﬁle
anatomical direction varied with ﬁlm orientation, anywhere from
anteroposterior to lateral, and the results were segregated accordingly. The metric was, in most cases, the difference in the coordi-

2

3

nates of the midpoints between the 50% level dose proﬁle points. In
a few instances where the targets were too close to each other to
produce clearly isolated dose peaks on the ﬁlm, the 65% proﬁle

3

3

4

5

3

5

3.A | Gamma analysis results
The gamma analysis results (3%G/1 mm) are detailed in Table 2.

6

10

Excellent agreement is observed for PF, with the lowest passing
rate of 96.1%. Pinnacle results are also solid, although for two
ﬁlms the passing rate slipped just below 90%. The 95% conﬁdence
intervals were 98.7–99.8% for PF and 95.2–98.4% for Pinnacle,
indicating that both systems can be considered in agreement with
experiment by current standards.29 It is therefore not surprising

97.7

Obl.45°

96.1

89.4

Obl.135°

99.1

99.0

Cor.

100

98.1

Sag.

99.4

95.7

Obl.135°

99.8

99.3

Obl.45°
Obl.135°

points were used to calculate the dose centroid.

3. | RESULTS

PF vs. Film Pinnacle vs. ﬁlm

100
99.9

98.3
99.2

Obl.45°

100

97.1

Obl.135°

100

99.4

Cor.

99.4

89.9

Obl.45°

99.7

98.6

Obl.135°

97.3

94.5

Cor.

98.3

94.3

Sag.

99.6

99.0

Obl.45°

99.3

97.5

Obl.135°

99.4

98.4

Ave

99.2

96.8

SD

1.1

3.1

that volumetric gamma analysis comparison between the two algorithms demonstrated 100% agreement for all plans at the 3%/

the dose‐error and the target distance from isocenter (r = 0.1 and

1 mm level.

−0.1 for PF and Pinnacle, respectively).

Fig. 2 illustrates the patterns of gamma analysis failures for the
ﬁlms with the lower passing rates. While some minor discrepancies
in the target areas are present, the majority of the disagreement for

3.C | Proﬁle alignment

both PF and Pinnacle, which is already quite small in absolute terms,

The results of dose proﬁles alignment between PF and ﬁlm are

is conﬁned to the low‐ or intermediate‐dose regions. The latter are

presented in Table 3. Within the range of accelerator motions

sometimes prominent when a ﬁlm plane glances the target and some

employed in the plans, submillimeter average displacements between

of the peripheral target dose is still evident on the ﬁlm. In that case,

the reconstructed and planned dose distribution centroids can

there is a high‐dose gradient in the direction perpendicular to the

be inferred.

ﬁlm, leading to dosimetric discrepancies due to residual geometric
misalignments. Those errors are not accounted for in the distance‐
to‐agreement since the gamma analysis is performed in two dimen-

4. | DISCUSSION

sions (the ﬁlm plane).
While the recent AAPM TG‐218 report29 prescribes the error

3.B | Peak target dose

thresholds and action levels for gamma analysis comparison between

Both PF and Pinnacle show agreement with measurement largely to

guidance for purely calculational or semi‐empirical veriﬁcation. We

within ±3%, which is satisfactory, particularly for the targets less

chose to retain the 3% dose‐error threshold from TG‐218, which is

measured and planned dose distributions, there is no such clear

than 1 cm in size. For all targets, the average dose‐errors were

also similar to the point‐dose veriﬁcation recommendations for com-

−0.4% ± 1.3% (range −2.2 to 2.4%, 99% CI −1.1 to 0.3%) and

plex non‐IMRT beams.30 Given the tight SRS spatial accuracy expec-

0.1% ± 1.6% (range −2.7 to 3.2%, 99% CI −0.8 to 1.0%) for PF and

tations, a 1 mm distance‐to‐agreement threshold seemed desirable.

Pinnacle respectively. Both distributions did not show signiﬁcant

Finally, the TG‐218 report unequivocally justiﬁes global dose‐error

deviation from normal by the D'Agostino & Pearson normality test (P

normalization for routine patient‐speciﬁc QA. With these criteria, the

≥0.2). There was no correlation between the dose‐error and the tar-

system in question — PerFRACTION — was able to achieve on

get size (Pearson correlation coefﬁcient r = 0.23 and 0.21 for PF and

average 99.2 ± 1.1% agreement rates with absolute ﬁlm measure-

Pinnacle, respectively). Similarly, there was no correlation between

ments. Volumetrically, all voxels in all plans agreed between PF and

656
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(a)

(b)

(c)

(d)

ET AL.

(e)
(f)

F I G . 2 . Gamma maps and isodose
overlays for PF vs. ﬁlm. (a&b): Oblique 45°
plane from Plan 1, (c&d): Oblique 135°
plane from Plan 5, and (e&f): Oblique 45°
plane from Plan 10.
T A B L E 3 Displacement between PF and ﬁlm dose proﬁles centers in different anatomical directions.
Direction

Craniocaudal

Anteroposterior

No. analyzed

27

4

Δ ±1SD (mm)

−0.3 ± 0.4

0.0 ± 0.6

Lt‐Rt

Obl. 45°

Obl. 135°

3

11

7

−0.1 ± 0.4

−0.2 ± 0.7

0.0 ± 0.4

the TPS at the same 3%/1 mm level. The point doses near the target

However, a bigger question remains on the role of calculations

center agreed between PF and ﬁlm to better than 3%, for the target

vs. measurements in patient‐speciﬁc dosimetric QA. It is a subject of

sizes ranging from 0.8 to 3.6 cm. The reconstructed dose centroid

ongoing debate,31 with the latest TG‐218 report29 acknowledging

positions derived from the EPID‐measured MLC apertures on a well‐

but not adjudicating the issue. We characterize the approach

aligned accelerator showed on average sub‐millimeter displacements

described in this paper as semi‐empirical or hybrid, as some of the

from ﬁlm measurements. The studied system is thus sufﬁciently

information (MLC apertures) is derived from independent measure-

accurate in the radiosurgical setting for routine semi‐empirical dose

ments, while other elements are harvested from the accelerator log

reconstruction.

ﬁles. In addition to the delivered MLC leaf positons, such approach
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deﬁnitively tests the integrity of the data transfer chain all the way

comprehensively validated for single‐isocenter multi‐target VMAT

from the TPS to the accelerator, which is one of the most important

SRS treatments against absolute ﬁlm measurements. With proper

aspects of the patient‐speciﬁc end‐to‐end tests. The beam model

understanding of its advantages and shortcomings, the tool can be

quality, which is the frequent culprit in the end‐to‐end head and

used in routine clinical practice.

neck phantom irradiation failures32 is also tested, but not by direct
dose measurements. We would argue that this level of scrutiny is
acceptable for routine QA (as opposed to system commissioning),
and furthermore 3D reconstruction with small voxels is more com-
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prehensive than, for example, experimental planar sampling with
large detector pitch arrays. Studying the sensitivity of the method to
induced MLC errors is outside the scope of this work, but it is likely
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itive ﬁndings (an error reported when there is none) is easily mitigated by measurement if necessary, a potential false negative (no
error reported when there is one) is more likely to slip through. The
risk of accelerator absolute calibration changes after the morning
checkout has always been considered sufﬁciently mitigated in conventional treatments by the redundancy of the dosimetry chain, and
the TG‐218 speciﬁcally recommends the IMRT QA measured dose
to be normalized to the daily output29 to exclude the inﬂuence of
the ﬂuctuations, which could otherwise consume a substantial part
of the error budget. Thus, the remaining weakest link in the tested
PF conﬁguration (and there are other options, not described in this
work) is the lack of independent veriﬁcation of the accelerator axes
positions (fractional MU, gantry angle, etc.) other than the MLC. If
an accelerator fails in such a fashion that the log ﬁles reﬂect the
intended plan that diverges from the delivered treatment, a dosimetric error may go unnoticed. It should be, however, argued that a random accelerator failure during treatment by deﬁnition cannot be
reliably caught by pre-treatment measurements in the ﬁrst place,
while any gradual parameter drift is more appropriately addressed by
an ongoing comprehensive QA program. Regarding systematic delivery deﬁciencies, with modern digital accelerators, the known issues
such as the overshoot phenomenon35 are largely considered mitigated.20 For example, for the TrueBeam accelerator with its 20 ms
controller interrogation cycle and strict delivery linearity enforcement inside each control point,36 even the gantry acceleration trajectory is highly predictable and reproducible.37 Therefore, while not
going as far as endorsing the log ﬁle analysis as a “premier SRS/SBRT
QA tool,”38 we nevertheless suggest that coupled with thorough
TPS commissioning and comprehensive ongoing accelerator QA program, the hybrid veriﬁcation method validated in this paper is a
viable tool that could be applied in clinical practice.

5. | CONCLUSIONS
A semi‐empirical volumetric dose veriﬁcation system extracts MLC
positions from the EPID movies, while the rest of the delivery control point information comes from the accelerator log ﬁles. This
combination is used to reconstruct dose on a patient CT dataset
with a fast superposition/convolution algorithm. The method was
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